ISSN 1671-5411 CN 11-5329/R
Wei WANG, Xian-Tao SONG, Yun-Dai CHEN, Fei YUAN, Feng XU, Min ZHANG, Kai TAN, Xing-Sheng YANG, Xian-Peng YU, Kong-Yong CUI, Shu-Zheng LYU. Growth differentiation factor-15 is a prognostic marker in patients with intermediate coronary artery disease. J Geriatr Cardiol 2020; 17(4): 210-216. doi: 10.11909/j.issn.1671-5411.2020.04.004
Citation: Wei WANG, Xian-Tao SONG, Yun-Dai CHEN, Fei YUAN, Feng XU, Min ZHANG, Kai TAN, Xing-Sheng YANG, Xian-Peng YU, Kong-Yong CUI, Shu-Zheng LYU. Growth differentiation factor-15 is a prognostic marker in patients with intermediate coronary artery disease. J Geriatr Cardiol 2020; 17(4): 210-216. doi: 10.11909/j.issn.1671-5411.2020.04.004

Growth differentiation factor-15 is a prognostic marker in patients with intermediate coronary artery disease

doi: 10.11909/j.issn.1671-5411.2020.04.004
Funds:

This study was supported by the Beijing Municipal Science and Technology Committee (D0906006000091) and the Ministry of Science and Technology of the People’s Republic of China, State Science and Technology Support Program (No.2011BAI11B05).

  • Received Date: 2019-09-02
  • Rev Recd Date: 2020-03-14
  • Publish Date: 2020-04-28
  • Background Growth differentiation factor-15 (GDF-15) is involved in multiple processes that are associated with coronary artery disease (CAD). However, little is known about the association between GDF-15 and the future ischemic events in patients with intermediate CAD. This study was conducted to investigate whether plasma GDF-15 constituted risk biomarkers for future cardiovascular events in patients with intermediate CAD. Methods A prospective study was performed based on 541 patients with intermediate CAD (20%–70%). GDF-15 of each patient was determined in a blinded manner. The primary endpoint was major adverse cardiac event (MACE), which was defined as a composite of all-cause death, nonfatal myocardial infarction, revascularization and readmission due to angina pectoris. Results After a median follow-up of 64 months, 504 patients (93.2%) completed the follow-up. Overall, the combined endpoint of MACE appeared in 134 patients (26.6%) in the overall population: 26 patients died, 11 patients suffered a nonfatal myocardial infarction, 51 patients underwent revascularization, and 46 patients were readmitted for angina pectoris. The plasma levels of GDF-15 (median: 1172.02 vs. 965.25 pg/mL, P = 0.014) were higher in patients with ischemic events than those without events. After adjusting for traditional risk factors, higher GDF-15 levels were significantly associated with higher incidence of the composite endpoint of MACE (HR = 1.244, 95% CI: 1.048–1.478, Quartile 4 vs. Quartile 1, P = 0.013). Conclusions The higher level of GDF-15 was an independent predictor of long-term adverse cardiovascular events in patients with intermediate CAD.
  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (322) PDF downloads(205) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return